GlyProVac ApS is a Danish APS based in Odense SØ, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2018, the company has 3 employees and reported a gross profit of -DKK 2.1m in its latest annual filing.
In its most recent annual report (2025), GlyProVac ApS reported a gross profit of -DKK 2.1m. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of DKK 5.2m.
At the end of 2025, current assets covered short-term debt 8.6 times.
Frequently asked questions
What is the CVR number of GlyProVac ApS?
GlyProVac ApS is registered with CVR / Virk under CVR 39724758.
What is the gross profit of GlyProVac ApS?
GlyProVac ApS reported a gross profit of -DKK 2.1m in 2025.
How many employees does GlyProVac ApS have?
GlyProVac ApS employs 3 people as of the latest annual report.
Who is the CEO of GlyProVac ApS?
Anders Boysen is the CEO of GlyProVac ApS.
Who is the chairman of GlyProVac ApS?
Ann Zahle Andersen chairs the board of GlyProVac ApS, in role since 2026.
Where is GlyProVac ApS headquartered?
GlyProVac ApS's registered address is Rørhatten 4.
